Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: PRUCALOPRIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved an original abbreviated new drug application (ANDA) for prucalopride by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)